Home > Financial Ratios > INDOCO REMEDIES

INDOCO REMEDIES
Fixed Capital/Sales

    Back to All Ratios
INDOCO REMEDIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
AD     Remove this Ad

INDOCO REMEDIES Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Fixed Capital/Sales(x) 1.110.880.800.780.93

What is the latest Fixed Capital/Sales ratio of INDOCO REMEDIES ?

The latest Fixed Capital/Sales ratio of INDOCO REMEDIES is 1.11 based on Mar2025 Consolidated results.
Year Fixed Capital/Sales
Mar20251.11
Mar20240.88
Mar20230.80
Mar20220.78
Mar20210.93

How is Fixed Capital/Sales of INDOCO REMEDIES Trending?

Years Fixed Capital/Sales % Change
Mar2025 1.11
26.14
Mar2024 0.88
10.00
Mar2023 0.8
2.56
Mar2022 0.78
-16.13
Mar2021 0.93 -

Other Financial Ratios of INDOCO REMEDIES


Compare Fixed Capital/Sales ratio of peers of INDOCO REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
INDOCO REMEDIES ₹1,744.5 Cr -3.7% -6.9% -11.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,528.0 Cr -3.1% 1.6% 5.6% Stock Analytics
DIVIS LABORATORIES ₹158,686.0 Cr -1.5% -3.4% 9.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹142,457.0 Cr -4.1% -1.2% 40.3% Stock Analytics
DR REDDYS LABORATORIES ₹106,339.0 Cr -1.5% -0.9% 16.8% Stock Analytics
CIPLA ₹100,056.0 Cr -5.7% -7.8% -13.2% Stock Analytics


INDOCO REMEDIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
INDOCO REMEDIES

-3.7%

-6.9%

-11.2%

SENSEX

-2.4%

-10.9%

0.2%


You may also like the below Video Courses